Beyfortus
CDC, FDA Expedite Additional Doses of Beyfortus for Infants
The CDC announced 77,000 additional doses of nirsevimab-alip, a long-acting monoclonal antibody designed to protect ...
NOVEMBER 17, 2023
Pediatricians: We Need Infrastructure to Provide Nirsevimab
There might be several obstacles to administering Beyfortus. Pediatricians are going to need help overcoming them.
AUGUST 10, 2023
Load more